Live search
TopFind is fetching the latest matches for your search.
We reviewed 39 live results for tnf inhibitors and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Tnf Inhibitors.
Sumber: Viatris / Fujifilm Kyowa Kirin Biologics
Deskripsi
Hulio is an adalimumab biosimilar listed in Singapore's National Drug Formulary. It is available in 40mg/0.8ml pre-filled pens and syringes for treating inflammatory conditions such as rheumatoid arthritis and psoriasis.
Paling cocok untuk
immune-mediated disorders, Singapore NDF access and subcutaneous administration
Penilaian
Sumber: Pfizer Private Limited
Deskripsi
Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases.
Paling cocok untuk
biologic therapy, chronic inflammation management and subcutaneous injection
Penilaian
Sumber: Samsung Bioepis / Organon
Deskripsi
Hadlima is an adalimumab biosimilar widely used for inflammatory diseases. While not a primary registered brand for commercial supply in Singapore, it has significant availability and approval in the United States, Australia, and Canada.
Paling cocok untuk
US healthcare market, Australian pharmaceutical access and Canadian healthcare patients
Penilaian
| Bandingkan | Hulio | Abrilada | Hadlima |
|---|---|---|---|
| Sumber | Viatris / Fujifilm Kyowa Kirin Biologics | Pfizer Private Limited | Samsung Bioepis / Organon |
| Deskripsi | Hulio is an adalimumab biosimilar listed in Singapore's National Drug Formulary. It is available in 40mg/0.8ml pre-filled pens and syringes for treating inflammatory conditions such as rheumatoid arthritis and psoriasis. | Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases. | Hadlima is an adalimumab biosimilar widely used for inflammatory diseases. While not a primary registered brand for commercial supply in Singapore, it has significant availability and approval in the United States, Australia, and Canada. |
| Paling cocok untuk | immune-mediated disorders, Singapore NDF access and subcutaneous administration | biologic therapy, chronic inflammation management and subcutaneous injection | US healthcare market, Australian pharmaceutical access and Canadian healthcare patients |
| Tag | |||
| Aksi | Lihat detail | Lihat detail | Lihat detail |
| Penilaian |
Jika Anda ingin memulai dari opsi yang paling seimbang, saya merekomendasikan:
"Hulio from Viatris / Fujifilm Kyowa Kirin Biologics."
Saya memilih ini karena A formulary-listed biosimilar providing a standard dosage option in Singapore.